William Morrison
Liverpool Heart and Chest Hospital NHS Trust
5 Papers
117 Citations
William Morrison is an academic researcher from Liverpool Heart and Chest Hospital NHS Trust. The author has contributed to research in topics: Internal medicine & Angioplasty. The author has an hindex of 5, co-authored 5 publications.
Chat about Author
Papers
Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial
Adeel Shahzad,Ian Kemp,Christine Mars,Keith S. Wilson,Claire Roome,Robert Cooper,Mohammed Andron,Clare Appleby,Michael Fisher,Aleem Khand,Babu Kunadian,Joseph D. Mills,John L. Morris,William Morrison,Shahzad Munir,Nicholas D. Palmer,Raphael A. Perry,David R. Ramsdale,Periaswamy Velavan,Rod Stables +19 more
TL;DR: Compared with bivalirudin, heparin reduces the incidence of major adverse ischaemic events in the setting of PPCI, with no increase in bleeding complications.
537
Evidence for free radical generation after primary percutaneous transluminal coronary angioplasty recanalization in acute myocardial infarction.
Ever D Grech,Nicholas J F Dodd,Malcolm J. Jackson,William Morrison,E B Faragher,David R. Ramsdale +5 more
TL;DR: Findings provide the first direct and quantitative evidence of free radical production in the immediate postrecanalization phase after thrombotic occlusion of a major coronary artery in humans.
102
Free-radical generation during angioplasty reperfusion for acute myocardial infarction
TL;DR: Direct and quantitative evidence of free-radical production in the early stage after recanalisation in a patient undergoing primary coronary angioplasty for acute myocardial infarction is described.
56
Outcome of left atrial appendage occlusion in high-risk patients
Ahmed Masoud,Ahmed Masoud,Stefano Bartoletti,Timothy Fairbairn,Ayush Khurana,Periaswamy Velavan,William Morrison,Afshin Khalatbari,Suneil Aggarwal,Nikhill Sharma,Paulus Kirchhof,Dhiraj Gupta +11 more
TL;DR: LAA occlusion may be a reasonable option for stroke prevention in high-risk patients with atrial fibrillation ineligible for anticoagulation, however, procedural complication rates are not insignificant, and patients remain at risk of serious adverse events and death even after successful implant.
15
Clinical outcomes of long coronary stents: a single-center experience.
Shukri S. Mushahwar,Jason R. Pyatt,Robert S. Lowe,William Morrison,Raphael A. Perry,David R. Ramsdale +5 more
TL;DR: The use of long coronary stents (>/= 30 mm) for the treatment of long diffuse native vessel disease, saphenous vein graft disease and long coronary dissections is associated with a reasonable procedural success rate and acceptable early and intermediate-term clinical outcomes.
7